Search

everythinglearnresearchcommunity

for

Search:↓

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Melatonin affects certain genes and pathways involved in cashmere goat hair growth.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

The hair follicle infundibulum plays a key role in skin health and disease, and understanding it better could lead to new skin disease treatments.

Hydrogel scaffolds can help wounds heal better and grow hair.

Vitamin D is crucial for health, and deficiency can cause hair loss and other health issues.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Older skin has higher cancer risk due to inflammation and stem cell issues.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Non-immune factors play a significant role in alopecia areata.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Enterococcus faecalis delays wound healing by disrupting cell functions and creating an anti-inflammatory environment.

Skin stem cells remember past inflammation, helping them respond better to future injuries and possibly aiding in treating skin issues.

There's a growing resistance to the antibiotic mupirocin in children's skin infections caused by MRSA in New York.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

MPZL3 is crucial for seborrheic dermatitis development.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

New treatments targeting T-cell pathways are needed for better alopecia areata management.